Treatments
Programme
Results
Experts
Resources
menu-close
WHAT WE TREAT
Weight loss
Weight loss
icon
Menopause
Menopause
icon
ACCOUNT
Log in
icon
OVERVIEW
Weight loss overview
Weight loss overview
icon
TREATMENTS
Explore all options
Explore all options
icon
Mounjaro
Mounjaro
Lose up to 23% body weight
icon
Wegovy
Wegovy
Lose up to 21% body weight
icon
Saxenda
Saxenda
Lose up to 10% body weight
icon
Orlos
Orlos
Lose up to 8% body weight
icon
PROGRAMME
How it works
How it works
icon
Coaching
Coaching
icon
App
App
icon
ABOUT
Results
icon
Experts
icon
RESOURCES
Guides & tips
icon
ACCOUNT
Log in
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
OUR CLINIC
Menopause overview
Menopause overview
icon
Pricing
icon
Clinicians
icon
TREATMENT PLANS
Hormone replacement therapy
icon
Testosterone treatment
icon
Cognitive behavioural therapy
icon
Vaginal treatments
icon
BLOOD TESTS
Women's midlife (MOT) blood test
icon
Monitor HRT blood test
icon
Start testosterone blood test
icon
WHAT WE TREAT
Skincare
New
icon
Perimenopause
icon
Menopause
icon
Sexual health
icon
Weight management
icon
LEARN
Guides
icon
Treatments
icon
ACCOUNT
Log in
icon
SUPPORT
FAQ
icon
Home/Guides & Tips/Medications/

Retatrutide, tirzepatide, or semaglutide?

Retatrutide, tirzepatide, or semaglutide? Comparing weight loss medications

Wondering how different weight loss medicines stack up? Here’s a head-to-head comparison of retatrutide vs tirzepatide vs semaglutide.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconUpdated 6th August 2025
Research-Based Comparison
Table of contents
  • What is retatrutide?
  • What is tirzepatide?
  • What is semaglutide?
  • Key differences between retatr...
  • Clinical data: semaglutide vs ...
  • Which medicine is better for w...
  • Ready to take the next step to...

Looking to try weight loss medication? There are a few options out there. For example, the weekly injections Wegovy and Mounjaro, which are brand names for semaglutide and tirzepatide, respectively. And in the next year or so, a new medicine called retatrutide is set to be available as well.

All of these medicines make you feel full by acting like your body’s natural hormones. But they each do that in their own way.

If you’re exploring which weight loss medication might be best for you, it’s important to understand the differences between them. We’ve got you—here’s a head-to-head comparison of retatrutide vs tirzepatide vs semaglutide.

What is retatrutide?

It’s a brand new weight loss medication that’s still being developed and is currently still in the clinical trial stage.

What sets retatrutide apart is that it mimics the behaviour of three hormones—GLP-1, GIP and GCG—rather than two (Mounjaro) or one (Wegovy). That’s why it’s sometimes given the nickname “triple G”. And this triple action suggests that it’s the most potent medicine of the lot.

Retatrutide is currently being investigated in clinical trials and isn’t due to be approved until at least mid-2026. But the results we have so far are impressive (more on that below!).

What is tirzepatide?

That would be the active ingredient in Mounjaro weight loss injections. It makes you feel full by bringing on the effects of the hunger hormones GLP-1 and GIP.

You might see Mounjaro being referred to as a GLP-1/GIP receptor agonist—which is just another way of describing how it works.

Mounjaro is approved in the UK as a treatment for weight loss and type 2 diabetes.

Don't wait to hit your health goals
Retatrutide isn’t available yet, but Wegovy and Mounjaro are already helping people lose weight. Start your journey today with proven treatments and support that sticks.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 100k customers across the UK

What is semaglutide?

And finally, we have semaglutide, the active ingredient in Wegovy and Ozempic.

These are two brand names for the same medicine. Semaglutide is called Ozempic when it’s used for type 2 diabetes (though Ozempic is sometimes prescribed off-label for weight management) and Wegovy when it’s used for weight loss.

Semaglutide acts like just one hormone, GLP-1. But it still works very well! If you take it for over a year alongside healthy lifestyle changes, you could lose around 17.5% of your starting weight. In a newer trial using a 7.2 mg dose, weight loss was up to 20.7% in people taking the higher dose for 72 weeks.

There’s also research into combining semaglutide with other hormones to boost weight loss further—such as CagriSema, which pairs semaglutide with cagrilintide for even more appetite control.

Key differences between retatrutide, tirzepatide and semaglutide

Okay, but how do these medicines compare? Let’s dive in. 

How they work

Semaglutide, tirzepatide and retatrutide are all separate medicines that work in their own way. To give you a quick recap:

  • Semaglutide acts like GLP-1
  • Tirzepatide acts like GLP-1 and GIP
  • Retatrutide acts like GLP-1, GIP and GCG

That means that they may all bring on different weight loss results (which is what the research shows).

Side effects

Because semaglutide and tirzepatide both act on the gut, they tend to bring on similar side effects. For both, the most common symptoms include nausea, constipation, vomiting, and diarrhoea.

How about tirzepatide and semaglutide vs retatrutide? There’s no official list of retatrutide side effects yet, because it isn’t approved. But it affects the gut, too. And in clinical research, the most commonly reported symptoms were the same as the above.

Side effects support at Voy

"If you're using Voy and you experience any side effects, rest assured that our expert clinicians are just a message or phone call away. They can adjust your dose, prescribe medication to ease your symptoms, or simply offer reassurance.

Everyone responds differently to weight loss treatment and we'll help you find what feels right for you."

Phoebe Fox - Weight Loss Specialist Clinician

Dosing

Though each of these medicines comes in different doses, they’re all weekly injections that are taken in a similar way.

For semaglutide and tirzepatide, you start on a low dose so that your body can adjust to the medicine, and then gradually move up to a higher strength every four weeks (provided that you aren’t getting any troublesome side effects).

It’s likely to be the same story for retatrutide, because that’s how it’s been taken in clinical trials.

Clinical data: semaglutide vs tirzepatide vs retatrutide

Now let’s take a look at weight loss results from clinical research.

Retatrutide

In a 48-week Phase II clinical trial, participants lost an average of 24.2% of their body weight. Impressively, 26% of participants lost at least 30% of their starting weight.

Tirzepatide (Mounjaro)

Based on results from a 72-week trial, estimated weight loss at 48 weeks is approximately 20.5% for the highest dose (15 mg).

Semaglutide (Wegovy)

At the current maximum approved dose of 2.4 mg, estimated 48-week weight loss is around 15.0%, based on data from the 72 week STEP-UP trial. However, using a 7.2 mg dose showed weight loss of up to 18% at week 48, suggesting that higher doses of semaglutide may help close the gap with other medications.

Which medicine is better for weight loss?

We’re asked this question a lot here at Voy. And it’s a tough one, because everyone can respond differently to medicines.

What’s most suitable for you depends on a bunch of factors, including your current health, medical history and your health goals. It also depends if you’ve tried weight loss medication before and whether you experienced side effects. Your provider will weigh all of that up when deciding which medicine to prescribe you.

This also feels like a good time to remind you that retatrutide isn’t approved yet, which means that a clinician can’t prescribe it to you. At the earliest, it might be available in mid-2026.

Ready to take the next step towards your health goals?

When combined with a healthy lifestyle, weight loss medication can be a gamechanger for some people. They can be a great option if you’ve tried to lose weight another way but didn’t see the results you hoped for.

You can get Mounjaro or Wegovy weight loss injections through our weight loss programme, plus dedicated support from our clinicians and coaches. We use a structured habit-change approach that’s backed by science and designed to transform your lifestyle.

Want to try it out? Take our short quiz to see if you’re eligible. Our clinicians will review and come back to you within minutes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
FAQ

Retatrutide vs tirzepatide vs semaglutide: FAQs

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Aronne, Louis J, et al. “Continued Treatment with Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity: the SURMOUNT-4 Randomised Clinical Trial.” JAMA,scribble-underline vol. 331, no. 1, 2024:38-48. https://jamanetwork.com/journals/jama/fullarticle/2812936.

icon²

Jastreboff, Ania M., et al. “Triple-hormone-receptor Agonist Retatrutide For Obesity—A Phase 2 Trial.” The New England Journal of Medicinescribble-underline, vol. 389, no. 6, 2023:514-526 www.nejm.org/doi/full/10.1056/NEJMoa2301972.

icon³

“Mounjaro: Information For The Patient.” Electronic Medicines Compendium.scribble-underline www.medicines.org.uk/emc/files/pil.15481.pdf. Accessed 23 May 2025.

icon⁴

“Wegovy: Information For The Patient.” Electronic Medicines Compendiumscribble-underline. www.medicines.org.uk/emc/files/pil.13800.pdf. Accessed 23 May 2025.

icon⁵

Wilding, John P.H., et al. “Once-weekly Semaglutide In Adults With Overweight Or Obesity.” The New England Journal of Medicinescribble-underline, vol. 384, no. 11, 2021:989-1002 www.nejm.org/doi/full/10.1056/NEJMoa2032183.

Take the first step towards weight loss that lasts.

card-image
Medication
Ozempic side effects: Is it safe?
Like all medicines, Ozempic can cause side effects, though they’re mild and manageable for most people. Here’s what you need to know.
card-image
Medication
Mounjaro and breast cancer
New research in mice suggests Mounjaro could slow breast cancer growth. But could this effect translate to humans?
card-image
Medication
Trump calls Ozempic a “fat pill”
The comment has raised questions about what Ozempic actually is, whether it’s a pill or an injection, and how well it really works for weight loss.
Have a question?
phone icon
020 3912 9885Monday - Friday 9am - 5pm
support icon
help@joinvoy.comWe aim to reply in 24hrs
email icon
press@joinvoy.comPress & media inquiries
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999.

Programme

  • How it works
  • Treatments
  • Coaching
  • The Voy App

Voy

  • Medical experts
  • Results

Legal

  • Privacy policy
  • Terms & Conditions
  • Terms of Sale
  • Complaints

Get help

  • Help Centre (FAQ)
facebooktwitterinstagram
Copyright 2025 Voy. All rights reserved.
Pharmacies: Manual PharmacySuperintendent Pharmacist: Vinisha KandaGPhC Registration: 2203475
registered pharmacycqc ratingcpd member